TITLE

Selective reporting of positive results from drug clinical trials is a well-documented problem, but a new study finds that trials of surgical treatments have an even worse track record

PUB. DATE
March 2013
SOURCE
MondayMorning;3/18/2013, Vol. 21 Issue 10, p1
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article presents information on a study related to selective reporting of trials of surgical treatments and other clinical trials. It informs that selective reporting of positive results from drug clinical trials is a well documented problem, but the trials of surgical treatments have an even worse effect on patients.
ACCESSION #
86435115

 

Related Articles

  • Can ‘phase IV’ work for you? Borfitz, Deborah // Medical Economics;6/6/2003, Vol. 80 Issue 11, p58 

    Focuses on the controversies behind phase IV clinical trials in the U.S. Emphasis on creating a potentiated drug combinations; Collaboration between doctors and pharmaceutical companies to increase drug sales; Quality of drug studies conducted.

  • N.O.'s research facilities prove big draw for clinical drug trials. Kamerick, Megan // New Orleans CityBusiness (1994 to 2008);10/20/2003, Vol. 24 Issue 17, p35 

    Reports on the prevalence of clinical drug trials in New Orleans, Louisiana. Number of trials taking place at the Louisiana State University Health Sciences Center; Impact of the prevalence of clinical trials on the economy of the city; Credibility of academic health science in conducting the...

  • Funding and Practice of Biomedical Research. Staropoli, John F. // JAMA: Journal of the American Medical Association;7/2/2003, Vol. 290 Issue 1, p112 

    Comments on biomedical research practice and funding in the United States. Discussion of an alliance between academia and life-science corporations, especially concerning clinical drug trials; Concern about conflicts of interest; Reference to a survey by Sameer Chopra in this issue which...

  • Global clinical trial laboratories decentralize. Rosenberg, Ronald // CenterWatch Monthly;Apr2014, Vol. 21 Issue 4, p1 

    The article reports that central laboratories which have played an important role in drug development, are now looking for decentralization and regional labs are becoming more active in global clinical trials. With sponsors seeking real-time data access and faster results, labs are conducting...

  • The Quality of Registration of Clinical Trials. Viergever, Roderik F.; Ghersi, Davina // PLoS Clinical Trials;Feb2011, Vol. 8 Issue 2, Special section p1 

    Background: Lack of transparency in clinical trial conduct, publication bias and selective reporting bias are still important problems in medical research. Through clinical trials registration, it should be possible to take steps towards resolving some of these problems. However, previous...

  • CNS. Lazarus, Kim // Medical Marketing & Media;Dec2008, Vol. 43 Issue 12, p51 

    The article presents information on clinical trials that were conducted to test the efficacy of drugs including Almorexant Actilion. A study in patients with primary insomnia indicated that Almorexant significantly improved the primary parameter of sleep efficiency. In another trial it was found...

  • Oncology. Galvin, Michael // Medical Marketing & Media;Dec2008, Vol. 43 Issue 12, p55 

    The article presents information on clinical trials related to oncology that were conducted to test the efficacy of drugs including Almorexant Actilion. Aflibercept Regeneron and Lucanix. Two studies examined aflibercept (VEGF Trap) as a single agent in recurrent ovarian and lung cancers. It was...

  • Applied Clinical Trials.  // Applied Clinical Trials;Dec2011, Vol. 20 Issue 12, p53 

    The article profiles the global publication, Applied Clinical Trials (ACT). The magazine reaches a circulation approximating 18,250 subscribers, twelve times a year and offering practical advice and information for trials professionals and the clinical trials industry. It also mentions that ACT...

  • A European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA). Ruperto, Nicolino; Eichler, Irmgard; Herold, Ralf; Vassal, Gilles; Giaquinto, Carlo; Hjorth, Lars; Valls-i-Soler, Adolf; Peters, Christina; Helms, Peter J.; Raymond, Agnès Saint // Archives of Disease in Childhood;Mar2012, Vol. 97 Issue 3, p185 

    The article discusses several national and international paediatric networks that are performing clinical trials in the paediatric population in Europe. It examines the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA), an organization establish to investigate...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics